These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
105 related items for PubMed ID: 2080583
1. [The prevention of neurotoxic reactions during the treatment of pulmonary tuberculosis in middle-aged and elderly patients]. Markova EF. Vrach Delo; 1990 Oct; (10):56-8. PubMed ID: 2080583 [Abstract] [Full Text] [Related]
3. [Use of quateron in the treatment of peptic ulcer in pulmonary tuberculosis]. Petrenko VM. Vrach Delo; 1979 Jul; (7):11-4. PubMed ID: 382632 [No Abstract] [Full Text] [Related]
4. [Intensive chemotherapy regimens in pulmonary tuberculosis with concomitant diabetes mellitus]. Cheren'ko SA. Vrach Delo; 1990 Sep; (9):87-8. PubMed ID: 2284784 [Abstract] [Full Text] [Related]
5. [The elimination of chemotherapy side effects in pulmonary tuberculosis patients]. Bal'tseva LB, Mel'nik GV, Man'ko VP. Vrach Delo; 1990 Apr; (4):71-3. PubMed ID: 2275176 [Abstract] [Full Text] [Related]
6. [Adverse neurotoxic reactions of chemotherapy for tuberculosis and their treatment]. Lysov AV, Mordyk AV, Zatvornitskiĭ VA, Kondria AV. Probl Tuberk Bolezn Legk; 2006 Apr; (9):45-8. PubMed ID: 17128801 [Abstract] [Full Text] [Related]
7. HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone free anti-tuberculosis treatment in Yaounde, Cameroon. Kuaban C, Bercion R, Koulla-Shiro S. East Afr Med J; 1997 Aug; 74(8):474-7. PubMed ID: 9487410 [Abstract] [Full Text] [Related]
13. [Tuberculostatic preparation tolerance in elderly patients with a chronic course of pulmonary tubercuosis and concomitant diseases]. Utkin VV, Mikheeva LP, Poleshchuk AK, Krylova NP. Probl Tuberk; 1980 Sep; (9):42-5. PubMed ID: 7422656 [No Abstract] [Full Text] [Related]
14. [Clinico-morphological comparisons in pulmonary tuberculosis of patients with toxico-allergic reactions]. Bogush LK, Lesnaia AA, Akmatov TA. Probl Tuberk; 1974 Sep; (2):21-5. PubMed ID: 4457900 [No Abstract] [Full Text] [Related]
15. [Adverse reactions of antituberculous agents, especially about its onset and duration]. Yamada H, Yasuoka A, Sasayama K, Doutsu Y, Hayashi T, Kohno S, Yamaguchi K, Hirota M, Hara K. Kekkaku; 1990 Sep; 65(9):563-8. PubMed ID: 2232434 [Abstract] [Full Text] [Related]
16. A study of pulmonary tuberculosis in the elderly. Das SK, Mukherjee RS, Ghosh IN, Halder AK, Saha SK. J Indian Med Assoc; 2007 Aug; 105(8):432, 436, 438-9. PubMed ID: 18236905 [Abstract] [Full Text] [Related]
17. [Dipromonium in the treatment of scleroderma patients]. Khamaganova IV. Vestn Dermatol Venerol; 1989 Aug; (6):67-70. PubMed ID: 2588793 [Abstract] [Full Text] [Related]
19. [Treatment of pulmonary tuberculosis in patients with drug dependence]. Zadremaĭlova TA, Aksenova KI. Probl Tuberk Bolezn Legk; 2003 Aug; (7):31-3. PubMed ID: 12939874 [Abstract] [Full Text] [Related]
20. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis]. Kang WL, Xie YG, Tan WG, Chu NH, Li L, You YH, Yang YZ, Wang XM, Yan XL, Miao ZP, Duanmu HJ. Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883 [Abstract] [Full Text] [Related] Page: [Next] [New Search]